Benzodiazepines for Anxiety: Masterclass

Wednesday, February 6, 2019

In this episode of the MDedge Psychcast, Jeffrey R. Strawn, MD, discusses the dogma around benzodiazepine use -- and when the evidence supports the use of those medications for anxiety disorders. Dr. Strawn, associate professor of psychiatry at the University of Cincinnati, checked in from the 2018 Psychopharmacology Update meeting in Cincinnati. And later, Dr. RK describes how a nudge from Alexa led her to practice what she preaches to patients. If you would like to respond to Dr. Strawn or Dr. Renee Kohanski, email us at podcasts@mdedge.com.

Contact us: podcasts@mdege.com

Twitter: @mdedgepsych

How to Listen

Podcast Participants

^{Lorenzo Norris, MD}

Lorenzo Norris, MD, is host of the MDedge Psychcast, editor in chief of MDedge Psychiatry, and assistant professor of psychiatry and behavioral sciences at George Washington University, Washington. He also serves as assistant dean of student affairs at the university, and medical director of psychiatric and behavioral sciences at GWU Hospital. Dr. Lorenzo Norris has no conflicts of interest.

^{Renee Kohanski, MD}

Renée S. Kohanski, MD, is a board-certified psychiatrist with additional training in forensic psychiatry. She has been a board examiner for the American Board of Psychiatry and Neurology, and has enjoyed a broad-based practice in academic, community, and forensic psychiatry. She is currently a solo practitioner and owner of RK Psychiatry Associates and serves on the Editorial Advisory Board of MDEdge Psychiatry. Talkers magazine describes Dr. Kohanski as “one of the most reliable ‘go-to’ sources for insights and information about psychiatry in the media today.” Dr. Renée Kohanski has no conflicts of interest.